Zytokin-vermitteltes Targeting von Adenovirusvektoren zur effizienten Transduktion hematopoietischer Zellen

细胞因子介导的腺病毒载体靶向用于造血细胞的有效转导

• 批准号: 22711144
• 负责人: Professor Dr. Florian Kreppel
• 金额: --
• 依托单位: Lehrstuhl für Biochemie und Molekulare Medizin
• 依托单位国家: 德国
• 项目类别: Priority Programmes
• 财政年份: 2006
• 资助国家: 德国
• 起止时间: 2005-12-31 至 2012-12-31
• 项目状态: 已结题
• 来源: https://gepris.dfg.de/gepris/projekt/22711144?language=en
• 关键词: Zytokin; vermitteltes; Targeting; von; Adenovirusvektoren

Adenovirus (Ad) vector targeting aims for the efficient gene transfer to specific cell types and tissues. So far, targeting efforts have met with limited success. Recently, we developed a novel geneti-chemical targeting platform that allows for the flexible use of different ligands even in combination with polymer shielding for the generation of truly retargeted Ad particles. However, our data indicate that not only the type of ligand, but also its position on the capsid strongly influences the intracellular fate of the vector particle and, therefore, transduction efficiency. This is probably due to post-receptor restrictions at the level of particle disassembly and/or particle trafficking. We will use the geneti-chemical targeting platform to characterize post-receptor restrictions for Ad vectors at the molecular and cell biology level. We will analyze the influence of ligand positioning and ligand copy number for three ligands with different intracellular fates: transferrin, EGF, and mannans. In addition, the influence of shielding polymers on the post-receptor fate of Ad vector particles will be characterized. Further, we will investigate the effect of bioresponsive bonds on post-receptor fate when used to link ligands and shielding polymers to the vector particles. Detailed analysis at a molecular level may form a basis for rational design of targeted Ad vectors. The results obtained may likely be transferable to other gene delivery systems.

腺病毒载体靶向是为了将基因有效地转移到特定的细胞和组织中。到目前为止，确定目标的努力取得的成功有限。最近，我们开发了一种新的遗传化学靶向平台，该平台允许灵活使用不同的配体，甚至与聚合物屏蔽相结合，以产生真正重靶向的Ad颗粒。然而，我们的数据表明，不仅配体的类型，而且其在衣壳上的位置强烈影响载体颗粒的细胞内命运，因此，转导效率。这可能是由于在颗粒分解和/或颗粒运输水平上的后受体限制。我们将使用基因化学靶向平台，在分子和细胞生物学水平上表征Ad载体的受体后限制。我们将分析三个配体的配体定位和配体拷贝数的影响与不同的细胞内命运：转铁蛋白，表皮生长因子和甘露聚糖。此外，将表征屏蔽聚合物对Ad载体颗粒的后受体命运的影响。此外，我们将研究生物响应键对后受体命运的影响时，用于连接配体和屏蔽聚合物的载体颗粒。在分子水平上的详细分析可以形成靶向Ad载体的合理设计的基础。所获得的结果可能会转移到其他基因传递系统。

项目成果

Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides

• DOI: 10.1002/jgm.1262
• 发表时间: 2008-12
• 期刊: The Journal of Gene Medicine
• 作者: Sigrid Espenlaub;Andreas Wortmann;T. Engler;S. Corjon;S. Kochanek;F. Kreppel

Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor.

• DOI: 10.1021/mp300366f
• 发表时间: 2013-01
• 期刊: Molecular pharmaceutics
• 影响因子: 4.9
• 作者: Alexandra Vetter;K. Virdi;Sigrid Espenlaub;W. Rödl;E. Wagner;P. Holm;C. Scheu;F. Kreppel;C. Spitzweg;M. Ogris